Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study
Background: Emerging evidence suggests immune checkpoint inhibitor (ICI) therapies can increase the risk of myocarditis —a life-threatening rare adverse event. High quality population-level evidence on the association remains lacking. We investigated this association in a large national cohort in Ch...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-02-01
|
| Col·lecció: | The Lancet Regional Health. Western Pacific |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2666606524002992 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|